New Horizons in Science

presented by

Age, sex and meddling microbes: An update on cancer immunotherapy

Topic: Cancer
Public Domain
Sunday, October 30, 2016 -
4:30pm to 5:30pm
Iberian, Omni la Mansión

Scientists' attempts to harness the immune system to fight cancer have met with mixed and often disappointing results. Tyler Curiel's lab is one of those working to find out why. He was the first to show that age makes a major difference in how the immune system responds to immunotherapy; an experiment showed that a therapy that beat back melanoma in young mice failed in old mice because of a specific additional component of the older animals' immune response.

They then designed the first immunotherapy that works in old but not young mice, based on understanding age-related changes. Since that experiment, new work has demonstrated the role of microflora in mediating immunotherapy response as well as significant male-female differences. Curiel will review the state of cancer immunotherapy and discuss his work exploring novel combination therapies and strategies to make resistant tumors more responsive.

Social media hashtag: #cancerpuzzles


Workshop Registration Required?: 

About CASW

The Council for the Advancement of Science Writing is committed to improving the quality and quantity of science news reaching the public. Directed and advised by distinguished journalists and scientists, CASW develops and funds programs that encourage accurate and informative writing about developments in science, technology, medicine and the environment.

Follow CASW